Dong-A ST Co., Ltd. (KRX:170900)

Market Cap	500.98B +10.2%
Revenue (ttm)	770.63B +10.0%
Net Income	-514.77M
EPS	-41.77
Shares Out	9.16M
PE Ratio	n/a
Forward PE	13.19
Dividend	686.27 (1.24%)
Ex-Dividend Date	Mar 10, 2026

Volume	64,957
Average Volume	31,845
Open	55,600
Previous Close	55,300
Day's Range	54,200 - 55,600
52-Week Range	40,900 - 59,200
Beta	0.47
RSI	53.47
Earnings Date	Feb 9, 2026

About Dong-A ST

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation; Growtropin II inj./AQ /cartridge to treat growth failure due to an inad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 1,679
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 170900